Physician profile
Taryn E Tyner
NPI 1457471617
$1,793.43
in general payments reported to CMS, 2019-2025
18 companies · $234 in 2025
The $234 reported for 2025 was more than what 78% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $99.55 · 2021: $324 · 2022: $144 · 2023: $354 · 2024: $496 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,084.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,083.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $546.48 | 2021-2025 | Qelbree, Qelbree |
| Pfizer INC. | $258.31 | 2019-2025 | |
| Tris Pharma INC | $233.74 | 2019-2021 | |
| Corium, LLC | $145.21 | 2021-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $126.13 | 2019-2023 | Jornay Pm |
| Glaxosmithkline, LLC. | $102.59 | 2024-2025 | Bexsero |
| Sanofi-Aventis U.S. LLC | $56.51 | 2025 | |
| Collegium Pharmaceutical, INC. | $51.50 | 2025 | Jornay Pm |
| Adlon Therapeutics L.P. | $46.30 | 2019-2021 | |
| Noven Therapeutics, LLC | $42.47 | 2025 | Xelstrym |
| Seqirus USA INC | $31.86 | 2021-2025 | Flucelvax |
| Takeda Pharmaceuticals U.S.A., INC. | $31.10 | 2021-2022 | |
| Shire North American Group INC | $25.64 | 2019 | |
| Travere Therapeutics, INC. | $23.78 | 2023 | Cholbam |
| Verrica Pharmaceuticals INC. | $22.70 | 2024 | Ycanth |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $19.98 | 2023 | |
| Biomarin Pharmaceutical INC. | $16.70 | 2023 | Voxzogo 1.2mg |
| Vertical Pharmaceuticals, LLC | $12.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taryn Tyner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.